Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.3, replacing the previous v3.6.2 tag.
    Difference
    0.1%
    Check dated 2026-07-04T04:19:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.2, indicating a platform update. This update appears to change the version reference rather than the study details or text on the page.
    Difference
    0.1%
    Check dated 2026-06-27T02:50:31.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now displays a recruitment status indicating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) to assist visitors. Additionally, the formatting of the Intervention/Treatment label was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:45.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.5.5, replacing the previous v3.5.4 tag.
    Difference
    0.1%
    Check dated 2026-06-05T13:30:34.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page. This appears to be a small metadata or formatting update and does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:55:26.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov UI/version footer was updated from **v3.5.2** to **v3.5.3**, indicating a site revision rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:01.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.